Dr. Kaouthar Lbiati is a biopharma business leader, board director, columnist, and public speaker. She serves on the boards of Hepion Pharmaceuticals (Nasdaq: HEPA) and Theralase Technologies (TSXV: TLT) and advises think tanks. Through media contributions and policy papers, she addresses healthcare system organization, technological transformation, industrial policy, ecosystem development, entrepreneurship, and Foreign Direct Investment (FDI) in emerging markets. A Doctor of Medicine (MD) with a master’s degree from the London School of Economics and Political Science (LSE), Dr. Lbiati was recognized for her contributions to life sciences and global health by being listed in Marquis Who’s Who (2024).
